Negotiable: Paramount Recruitment: Are you an experienced Computational Biologist keen to use their skills to significantly improve the lives of patients and their families suffering from neurodegerative and psychiatric diseases? Want an opportunity to work in an fast-paced, scientifically Germany

Funding Opportunity PA-17-447 from the NIH Guide for Grants and Contracts. The reproducibility and comparability of dietary supplement research is enhanced through rigorous analytical characterization of key experimental materials. The publication of analytical methods which have been thoroughly validated for specific, precise, accurate, and sensitive quantitative determination of chemical constituents of dietary supplements therefore makes critical contributions to the rigor and reproducibility of biomedical research. This FOA will build on existing NIH awards to support the performance and publication of formal single-laboratory validation studies of relevant quantitative analytical methods. The methods proposed for validation must be used to identify and quantify chemical constituents (active or marker chemical compounds, adulterants, contaminants) or metabolites thereof in experimental reagents, raw materials, and/or clinical specimens (for example urine or plasma samples). Methods must have been developed or utilized in fulfillment of the active parent grants specific aims. Candidate constituents for quantitative method validation studies may include (but are not limited to): phytochemicals, nutrients, and potentially deleterious substances such as pesticides and mycotoxins. Multi-laboratory validation studies will not be supported through this FOA.

Funding Opportunity RFA-HL-18-024 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate research on cardiovascular and pulmonary physiologic and health effects of electronic cigarette (e-cigarette) exposure. This FOA invites applications addressing the effects of e-cigarettes on the cardiovascular and pulmonary systems, alone or in combination. Studies involving clinical populations, animal models and/or cell preparations would all be considered responsive. Research may examine the effects of the whole e-cigarette aerosol or of individual components or constituents. Research may also examine where aerosols, components, or constituents deposit in the airways and resulting heart and/or lung consequences.

Notice NOT-CA-17-075 from the NIH Guide for Grants and Contracts

Notice NOT-CA-17-076 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Graduate Quantitative Scientist - Oxford This is a very interesting opportunity for a PhD or MSc or BSc graduate to join a leading biotech company based in Oxford. You will have the chance to work with some of the greatest minds in the genomics field, de Oxfordshire, England

Funding Opportunity PA-17-444 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Research Project Grant (R01) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. Applications may propose studies using either single or mixed methods. Proposed approaches may include but are not limited to data-generating qualitative and quantitative approaches, legal, economic and normative analyses, and other types of analytical and conceptual research methodologies, such as those involving the direct engagement of stakeholders.

Funding Opportunity PA-17-445 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Small Research Grant (R03) applications to study the ethical, legal and social implications (ELSI) of human genome research. These applications should be for small, self-contained research projects, such as those that involve single investigators. Of particular interest are projects that propose normative or conceptual analyses, including focused legal, economic, philosophical, anthropological, or historical analyses of new or emerging issues. This mechanism can also be used for the collection of preliminary data and the secondary analysis of existing data.

Funding Opportunity PA-17-446 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. These applications should propose single or mixed methods studies that break new ground, extend previous discoveries in new directions or develop preliminary data in preparation for larger studies. Of particular interest are studies that explore the implications of new or emerging genomic technologies or novel uses of genomic information.

Collaborate with protein engineering, computational biology, T cell redirecting therapy group and clinical development group to pursue the most promising drug...
From Pfizer Inc. - Tue, 01 Aug 2017 06:58:51 GMT - View all California jobs

Funding Opportunity RFA-RM-17-011 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) addresses the need for a robust National Metabolomics Data Repository to store, and make publicly available, raw and processed metabolomic data generated by large NIH programs, individual research grants, and other biomedical research groups. Data, associated metadata, and the essential tools critical for accessing the key information will be housed in a cloud computing environment accessible for searching and reanalysis by the biomedical research community. The Metabolomics Data Repository and Coordination Center (DRCC), created in Stage I of the Common Fund Metabolomics Program, has begun to address this need. In the transition to a National Metabolomics Data Repository, the successful applicant is expected to continue and enhance the current technical capabilities of the Data Repository and create a governance structure that engages the wider metabolomics community to guide the repositorys efforts toward continual technical improvement and expansion and policy development for data deposition, access, and citation.

Funding Opportunity RFA-RM-17-012 from the NIH Guide for Grants and Contracts. The goal of this cooperative agreement Funding Opportunity Announcement (FOA) is to address key challenges in analyzing and interpreting metabolomics data by developing novel tools to facilitate metabolomics data analysis and interpretation. Specifically, successful awardees will develop new or enhanced computational approaches or tools that facilitate metabolomics data analysis, interpretation, and integration. Generalizable, scalable, and portable solutions appropriate for scientists with limited expertise in informatics are particularly encouraged. Projects are not intended to supplement ongoing metabolomics analyses, but to provide tools for broader use by the biomedical research community.

Funding Opportunity RFA-RM-17-013 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to establish Compound Identification Development Cores (CIDC) to develop innovative approaches to enhance compound identification of the most significant, biomedically-relevant unknown metabolites. The ultimate goal of this FOA is to expand the repertoire of biologically relevant compounds that can be quickly and inexpensively identified in high throughput metabolomics experiments. An interdisciplinary approach and partnership among metabolomics experts, biomedical researchers, chemists, and computational experts will be integral to the success of this goal, and advances made through this initiative are expected to be catalytic to the field.

Funding Opportunity RFA-RM-17-014 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications to establish a Stakeholder Engagement and Program Coordination Center (SEPCC) to coordinate the required activities of the Common Fund Metabolomics Program Consortium; to engage the stakeholder community in identifying and developing strategies to address outstanding concerns in the application of metabolomics to biomedical research; and to promote use of Consortium resources by the greater biomedical research community. The Common Fund Metabolomics Program views community engagement and multi-directional communication as essential to overcome challenges in realizing the potential of metabolomics in biomedical research.

We seek a talented, collaborative inter-disciplinary scientist to empower data-driven decisions by ways of integrative computational analysis of public and...
From Celgene - Tue, 01 Aug 2017 00:00:01 GMT - View all Massachusetts jobs

Some familiarity with NGS bioinformatics analysis would be helpful. This will be a hybrid role dedicated to supporting QIAGEN’s consumable products for next...
From QIAGEN - Mon, 31 Jul 2017 23:55:14 GMT - View all United States jobs

Positions are available for PhD level candidates with deegrees in Statistics, Biostatistics, Bioinformatics, Computational Biology or other Quantitative fields...
From Mount Sinai Health System - Mon, 31 Jul 2017 20:04:22 GMT - View all United States jobs

Next Generation sequencing data analysis experience required, and familiarity with evolutionary lineage analysis software preferred....
From University of Massachusetts Medical School - Mon, 31 Jul 2017 18:38:51 GMT - View all Worcester, MA jobs

Must have expertise in oncology and translational science and data analysis. The role a strong background in cancer biology, genomic and statistical analysis....
From NantWorks - Mon, 31 Jul 2017 18:17:16 GMT - View all Rockville, MD jobs

Celgene: DescriptionCelgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health.  We value San Diego, California (US)